Estimating opium use prevalence at the national and provincial levels in Iran: a modelling study

Opium consumption was recently classified as carcinogenic to humans by the International Agency for Research on Cancer (IARC). With Iran having the highest global prevalence of opium consumption, understanding the national and provincial prevalence of opium use is critical for cancer control efforts. This study integrated multiple data sources to estimate the prevalence of opium use across Iran. Using population-based cohorts and case-control studies we calculated opium use prevalence for 17 provinces of Iran. A regression model was then developed to explain geographical variation in opium use prevalence, incorporating demographic, socioeconomic, and opium-related national enforcement variables. The model was trained and validated using leave-one-out cross-validation for the 17 provinces with individual-level data, and was subsequently used to predict prevalence in the 14 remaining provinces lacking individual-level data. The age-standardized predicted prevalence of opium use among Iranian adults aged > 30 years was estimated at 5.93% (95% CI 2.76–8.20%), with a significant difference between men [10.40% (95% CI 4.69–14.30%)], and women [1.46% (95% CI 0.83–2.09%)]. Older age, lower socioeconomic status, unemployment, and higher quantities of seized opium were associated with higher opium use prevalence at provincial levels (all P-values < 0.05). Significant geographical variations in opium use prevalence were observed, with the highest rates estimated for the eastern provinces bordering Afghanistan, the world’s largest producer of opium, and the lowest rates in the northwestern provinces. The highest rates were calculated for Sistan and Baluchestan (15.00%), Golestan (13.43%), and Qom (13.07%), while the lowest were in Markazi (1.30%), Ilam (1.30%), and Zanjan (1.32%). Although the overall prevalence differed substantially between men and women, the geographic distribution patterns were similar for both. Opium consumption is highly prevalent among Iranian men and in populations residing in the eastern and southeastern provinces. Targeted public health interventions are urgently needed to reduce opium use, particularly in high-risk regions. These efforts should be integrated into national cancer control programs to effectively address the associated health burden.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-03-09
DOI
https://doi.org/10.1038/s41598-026-38294-0
Primary Topic
HIV, Drug Use, Sexual Risk
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Estimating opium use prevalence at the national and provincial levels in Iran: a modelling study

Abbas Rezaianzadeh, Moluk Hadi Alijanvand, Maryam Hadji, N Saki et al.
Scientific Reports
HIV, Drug Use, Sexual Risk
article

Estimating opium use prevalence at the national and provincial levels in Iran: a modelling study

Abbas Rezaianzadeh, Moluk Hadi Alijanvand, Maryam Hadji, N Saki, Hossein Fallahzadeh, Farhad Pourfarzi, Farhad Moradpour, Hossein Poustchi, Mehdi Shahmoradi, Javad Harooni, Parvin Khalili, Hamideh Rashidian, Kazem Zendehdel, Mahmood Moosazadeh, Mehdi Hatami Goloujeh, F Ghorat, Afarin Rahimi-Movaghar, Farid Najafi, Rahim Khalilzadeh, Reza Malekzadeh, Mojtaba Farjam, Saeed Nemati, Nour Mohammad Bakhshani, Ali Akbar Haghdoost, Mahdi Sheikh, Mohammad Reza Fattahi, Mohammadreza Naghipour, Farin Kamangar, Ali Fakhari Dehkharghani
article en

Abstract

Opium consumption was recently classified as carcinogenic to humans by the International Agency for Research on Cancer (IARC). With Iran having the highest global prevalence of opium consumption, understanding the national and provincial prevalence of opium use is critical for cancer control efforts. This study integrated multiple data sources to estimate the prevalence of opium use across Iran. Using population-based cohorts and case-control studies we calculated opium use prevalence for 17 provinces of Iran. A regression model was then developed to explain geographical variation in opium use prevalence, incorporating demographic, socioeconomic, and opium-related national enforcement variables. The model was trained and validated using leave-one-out cross-validation for the 17 provinces with individual-level data, and was subsequently used to predict prevalence in the 14 remaining provinces lacking individual-level data. The age-standardized predicted prevalence of opium use among Iranian adults aged > 30 years was estimated at 5.93% (95% CI 2.76–8.20%), with a significant difference between men [10.40% (95% CI 4.69–14.30%)], and women [1.46% (95% CI 0.83–2.09%)]. Older age, lower socioeconomic status, unemployment, and higher quantities of seized opium were associated with higher opium use prevalence at provincial levels (all P-values < 0.05). Significant geographical variations in opium use prevalence were observed, with the highest rates estimated for the eastern provinces bordering Afghanistan, the world’s largest producer of opium, and the lowest rates in the northwestern provinces. The highest rates were calculated for Sistan and Baluchestan (15.00%), Golestan (13.43%), and Qom (13.07%), while the lowest were in Markazi (1.30%), Ilam (1.30%), and Zanjan (1.32%). Although the overall prevalence differed substantially between men and women, the geographic distribution patterns were similar for both. Opium consumption is highly prevalent among Iranian men and in populations residing in the eastern and southeastern provinces. Targeted public health interventions are urgently needed to reduce opium use, particularly in high-risk regions. These efforts should be integrated into national cancer control programs to effectively address the associated health burden.

Scientific ReportsVol. 16(1)
Ahvaz Jundishapur University of Medical Sciences (IR), Tabriz University of Medical Sciences (IR), Tampere University (FI), Shahrekord University of Medical Sciences (IR), Shiraz University of Medical Sciences (IR), Guilan University of Medical Sciences (IR), Shahid Sadoughi University of Medical Sciences and Health Services (IR), Kerman University of Medical Sciences (IR), Kurdistan University of Medical Sciences (IR), Ardabil University of Medical Sciences (IR), Urmia University (IR), Kermanshah University of Medical Sciences (IR), Yasuj University of Medical Sciences (IR), Hormozgan University of Medical Sciences (IR), Zahedan University of Medical Sciences (IR), Fasa University of Medical Sciences (IR), Sabzevar University of Medical Sciences (IR), Centre international de recherche sur le cancer (FR), Tehran University of Medical Sciences (IR), Morgan State University (US), Rafsanjan University of Medical Sciences (IR), Mazandaran University of Medical Sciences (IR)
World Health Organization
Openalex Percentile: Top 31%
HIV, Drug Use, Sexual Risk
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.